| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1086111700 |
| P356 | DOI | 10.1186/S40880-017-0217-4 |
| P932 | PMC publication ID | 5477375 |
| P698 | PubMed publication ID | 28629389 |
| P50 | author | Amit K Tiwari | Q51057202 |
| P2093 | author name string | Charles R Ashby | |
| Haneen Amawi | |||
| P2860 | cites work | Bioavailability of Phenolic Antioxidants Associated with Dietary Fiber: Plasma Antioxidant Capacity After Acute and Long-Term Intake in Humans | Q58630653 |
| Nanoemulsions for delivery of flavonoids: formulation andin vitrorelease of rutin as model drug | Q60587481 | ||
| Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic Consequences | Q61812662 | ||
| Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17 beta-estradiol | Q71378142 | ||
| Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells | Q71725485 | ||
| Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder | Q73017793 | ||
| Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway | Q73128493 | ||
| Intake of flavonoids and lung cancer | Q73365478 | ||
| Bioavailabilities of quercetin-3-glucoside and quercetin-4'-glucoside do not differ in humans | Q73763511 | ||
| Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans | Q74535186 | ||
| In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production | Q76385528 | ||
| Contribution of caffeine and flavanols in the induction of hepatic Phase II activities by green tea | Q77291834 | ||
| Intestinal bacterial metabolism of flavonoids and its relation to some biological activities | Q77754123 | ||
| A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer | Q80244055 | ||
| Intestinal efflux transporters and drug absorption | Q81636120 | ||
| Optimization of a heterologous pathway for the production of flavonoids from glucose | Q83410228 | ||
| Noncovalent interaction of dietary polyphenols with bovine hemoglobin in vitro: molecular structure/property-affinity relationship aspects | Q84477161 | ||
| Probing the binding sites of resveratrol, genistein, and curcumin with milk β-lactoglobulin | Q85718309 | ||
| Interaction of cyanidin-3-O-glucoside with three proteins | Q86761182 | ||
| Flavonoids: biosynthesis, biological functions, and biotechnological applications | Q21129214 | ||
| Human ATP-binding cassette (ABC) transporter family | Q21245457 | ||
| Grapefruit-medication interactions: forbidden fruit or avoidable consequences? | Q24611177 | ||
| The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility | Q26767195 | ||
| Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives | Q26770933 | ||
| Xenobiotics: Interaction with the Intestinal Microflora | Q26795702 | ||
| Chemistry and biological activities of flavonoids: an overview | Q26828856 | ||
| Flavonoid bioavailability and attempts for bioavailability enhancement | Q27009155 | ||
| Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. | Q27692081 | ||
| Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy | Q28076840 | ||
| Dietary flavonoids: bioavailability, metabolic effects, and safety | Q28203552 | ||
| Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats | Q28207260 | ||
| Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells | Q28240326 | ||
| The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms | Q28271120 | ||
| Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice | Q28320197 | ||
| Direct isolation of flavonoids from plants using ultra-small anatase TiO₂ nanoparticles | Q28396633 | ||
| Host-gut microbiota metabolic interactions | Q29615104 | ||
| Cancer chemoprevention with dietary phytochemicals | Q29617743 | ||
| Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol | Q30321006 | ||
| Preparative isolation and purification of five flavonoid glycosides and one benzophenone galloyl glycoside from Psidium guajava by high-speed counter-current chromatography (HSCCC). | Q30718566 | ||
| Chemistry of silybin | Q30834026 | ||
| In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data | Q30987583 | ||
| A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties | Q31121766 | ||
| Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells | Q31512518 | ||
| Biological properties of citrus flavonoids pertaining to cancer and inflammation | Q31922880 | ||
| Summary of information on human CYP enzymes: human P450 metabolism data | Q32103802 | ||
| Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells | Q33180798 | ||
| A review on structure-activity relationship of dietary polyphenols inhibiting α-amylase | Q38079845 | ||
| Bioavailability of quercetin: problems and promises | Q38091526 | ||
| Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect | Q38114495 | ||
| Novel fermentation processes for manufacturing plant natural products | Q38184010 | ||
| Diversity in ABC transporters: type I, II and III importers | Q38243039 | ||
| Systems metabolic engineering of microorganisms to achieve large-scale production of flavonoid scaffolds | Q38243730 | ||
| The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade | Q38305824 | ||
| Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells | Q38451529 | ||
| A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells | Q38476506 | ||
| Anticarcinogenic Effects of Dietary Phytoestrogens and Their Chemopreventive Mechanisms | Q38495331 | ||
| Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases | Q38515477 | ||
| Flavonoids with Therapeutic Potential in Prostate Cancer | Q38601767 | ||
| Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade | Q38616109 | ||
| Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences | Q38733345 | ||
| Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer. | Q38733914 | ||
| Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo | Q38746642 | ||
| Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. | Q38799165 | ||
| Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations | Q38805238 | ||
| Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells | Q38817350 | ||
| Flavonoids in Neurodegeneration: Limitations and Strategies to Cross CNS Barriers. | Q38925494 | ||
| Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes | Q38934642 | ||
| Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. | Q39071920 | ||
| Milk thistle's active components silybin and isosilybin: novel inhibitors of PXR-mediated CYP3A4 induction | Q39151905 | ||
| 8-C-(E-phenylethenyl)quercetin from onion/beef soup induces autophagic cell death in colon cancer cells through ERK activation | Q39349931 | ||
| Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. | Q39560592 | ||
| Characterization of flavonoid-protein interactions using fluorescence spectroscopy: Binding of pelargonidin to dairy proteins | Q39566655 | ||
| Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats | Q39587517 | ||
| The UVA and aqueous stability of flavonoids is dependent on B-ring substitution | Q39599550 | ||
| Enhanced Stability and Intracellular Accumulation of Quercetin by Protection of the Chemically or Metabolically Susceptible Hydroxyl Groups with a Pivaloxymethyl (POM) Promoiety | Q39629939 | ||
| Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors | Q39709437 | ||
| Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. | Q39720612 | ||
| Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells | Q39817646 | ||
| Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner | Q39871177 | ||
| Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line | Q39919197 | ||
| Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals | Q39973921 | ||
| Drug metabolism by intestinal microorganisms | Q40012549 | ||
| Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery. | Q50533550 | ||
| Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. | Q50797166 | ||
| Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress. | Q50891748 | ||
| Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. | Q51088695 | ||
| Quercetin derivatives as novel antihypertensive agents: Synthesis and physiological characterization. | Q51320238 | ||
| Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia. | Q51521395 | ||
| In Vitro Release and Bioavailability of Silybin from Micelle-Templated Porous Calcium Phosphate Microparticles. | Q51605943 | ||
| Metabolic engineering of Escherichia coli for (2S)-pinocembrin production from glucose by a modular metabolic strategy. | Q51843169 | ||
| Interactions of milk α- and β-casein with malvidin-3-O-glucoside and their effects on the stability of grape skin anthocyanin extracts. | Q52985644 | ||
| The influence of ABCB1 polymorphism C3435T on the pharmacokinetics of silibinin. | Q53273555 | ||
| Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. | Q53416340 | ||
| Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. | Q53472909 | ||
| Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies. | Q53664220 | ||
| The inhibitory effect of polyphenols on human gut microbiota. | Q54321797 | ||
| Dietary Flavonoids and the Risk of Colorectal Cancer | Q57569947 | ||
| Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1 ) expression caused by arsenite | Q58449743 | ||
| New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity. | Q40318991 | ||
| Ultrasound-assisted extraction of total flavonoids from Aconitum gymnandrum | Q40376561 | ||
| Transcriptional changes in human Caco-2 colon cancer cells following exposure to a recurrent non-toxic dose of polyphenol-rich chokeberry juice | Q40621559 | ||
| Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. | Q40635163 | ||
| Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. | Q40782779 | ||
| Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). | Q40907122 | ||
| Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism | Q40951975 | ||
| Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. | Q41035469 | ||
| The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. | Q41075336 | ||
| Phenolics: prooxidants or antioxidants? | Q41675355 | ||
| Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2. | Q41919107 | ||
| Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives | Q42023392 | ||
| Optimization of the extraction of total flavonoids from Scutellaria baicalensis Georgi using the response surface methodology | Q42068978 | ||
| The effects of selected flavonoids on cytochromes P450 in rat liver and small intestine | Q42126984 | ||
| Metabolic fate of [14C] quercetin in the ACI rat. | Q42260381 | ||
| Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases | Q42441688 | ||
| Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. | Q42548563 | ||
| Role of ABC transporters in cancer chemotherapy. | Q42637698 | ||
| Selective inhibition of methoxyflavonoids on human CYP1B1 activity | Q42942291 | ||
| Response surface optimization of ultrasound-assisted flavonoids extraction from the flower of Citrus aurantium L. var. amara Engl | Q43121378 | ||
| A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer | Q43176099 | ||
| Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects | Q43268376 | ||
| Glycosylation of dietary flavonoids decreases the affinities for plasma protein. | Q43282602 | ||
| Optimisation of ultrasound assisted extraction of phenolic compounds from Sparganii rhizoma with response surface methodology | Q43435795 | ||
| Phytoestrogen interaction with estrogen receptors in human breast cancer cells | Q43548451 | ||
| In vitro availability of flavonoids and other phenolics in orange juice. | Q43549984 | ||
| Inhibition of environmental estrogen-induced proliferation of human breast carcinoma MCF-7 cells by flavonoids | Q43712657 | ||
| Flavonol and flavone intake and the risk of cancer in male smokers (Finland). | Q43802977 | ||
| Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). | Q43882404 | ||
| Fungal ABC transporters and microbial interactions in natural environments | Q44210011 | ||
| Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans | Q44456584 | ||
| Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study | Q44525772 | ||
| Chemoprevention of skin cancer by the flavonoid fraction of Saraca asoka | Q44742224 | ||
| In vitro metabolism of anthocyanins by human gut microflora | Q45017152 | ||
| Metabolism of berry anthocyanins to phenolic acids in humans. | Q46115132 | ||
| Flavonoids, proanthocyanidins, and the risk of stomach cancer | Q46116279 | ||
| Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships | Q46176653 | ||
| Human gut microbial degradation of flavonoids: structure-function relationships. | Q46482735 | ||
| Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT? | Q46505266 | ||
| Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (-)epigallocatechin-3-gallate from green tea extract: a human study | Q46618958 | ||
| Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats | Q46754360 | ||
| PVP- coated naringenin nanoparticles for biomedical applications - In vivo toxicological evaluations | Q47865194 | ||
| Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression | Q47922922 | ||
| Flavonoid Interaction with a Chitinase from Grape Berry Skin: Protein Identification and Modulation of the Enzymatic Activity. | Q50227949 | ||
| Kinetic solubility and dissolution velocity of rutin nanocrystals | Q33398423 | ||
| Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells | Q33606155 | ||
| An inventory of the human ABC proteins | Q33784414 | ||
| Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease | Q33957385 | ||
| Bioavailability challenges associated with development of anti-cancer phenolics | Q34057398 | ||
| Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers | Q34066706 | ||
| The therapeutic potential of flavonoids | Q34075072 | ||
| Natural products: a continuing source of novel drug leads | Q34328933 | ||
| Dietary flavonoids and cancer risk: evidence from human population studies | Q34372348 | ||
| Effect of different light intensities on total phenolics and flavonoids synthesis and anti-oxidant activities in young ginger varieties (Zingiber officinale Roscoe). | Q34378149 | ||
| Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways | Q34496694 | ||
| Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. | Q34501881 | ||
| Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo | Q34507722 | ||
| Which sources of flavonoids: complex diets or dietary supplements? | Q34591974 | ||
| The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants | Q34641271 | ||
| Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA) | Q35274880 | ||
| Flavonoids: A versatile source of anticancer drugs | Q35533265 | ||
| Metabolism of Tea Flavonoids in the Gastrointestinal Tract | Q35547532 | ||
| Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance | Q35642041 | ||
| Black Currant Anthocyanins Attenuate Weight Gain and Improve Glucose Metabolism in Diet-Induced Obese Mice with Intact, but Not Disrupted, Gut Microbiome | Q35661178 | ||
| C-ring cleavage of flavonoids by human intestinal bacteria | Q35735745 | ||
| Isoflavone and Soyfood Intake and Colorectal Cancer Risk: A Case-Control Study in Korea | Q35843727 | ||
| Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. | Q35852614 | ||
| Ellagitannins and Flavan-3-ols from Raspberry Pomace Modulate Caecal Fermentation Processes and Plasma Lipid Parameters in Rats. | Q35878329 | ||
| Ultrasound-assisted extraction of total flavonoids from Inula helenium | Q36020982 | ||
| Flavonoids: from cell cycle regulation to biotechnology | Q36100201 | ||
| A new drug nanocrystal self-stabilized Pickering emulsion for oral delivery of silybin | Q36117120 | ||
| Influence of Intestinal Microbiota on the Catabolism of Flavonoids in Mice | Q36177337 | ||
| Biological and Chemical Aspects of Natural Biflavonoids from Plants: A Brief Review | Q36185293 | ||
| Flavonoid-drug interactions: effects of flavonoids on ABC transporters | Q36385218 | ||
| Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts | Q36405847 | ||
| Pharmacokinetics and Relative Bioavailability of Flavonoids between Two Dosage Forms of Gegen-Qinlian-Tang in Rats. | Q36466144 | ||
| New insights on the anticancer properties of dietary polyphenols. | Q36482626 | ||
| Genistein and Glyceollin Effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco-2 Cells | Q36512849 | ||
| De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae | Q36517423 | ||
| Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. | Q36595359 | ||
| Dietary flavonoid intake and risk of stomach and colorectal cancer | Q36637683 | ||
| Enhanced bioactivity of silybin B methylation products | Q36778757 | ||
| Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study | Q36826807 | ||
| Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy | Q36840439 | ||
| Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. | Q36854285 | ||
| Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ | Q36886503 | ||
| Effects of various temperatures and pH values on the extraction yield of phenolics from litchi fruit pericarp tissue and the antioxidant activity of the extracted anthocyanins | Q37083481 | ||
| Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort | Q37105257 | ||
| Interindividual differences in response to plant-based diets: implications for cancer risk | Q37179160 | ||
| Flavonoid intake and ovarian cancer risk in a population-based case-control study | Q37244256 | ||
| Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle | Q37374001 | ||
| An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study | Q37422723 | ||
| Pharmacosomes: the lipid-based new drug delivery system | Q37515443 | ||
| Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. | Q37526729 | ||
| Interaction between phenolics and gut microbiota: role in human health. | Q37542185 | ||
| Lipid dependence of ABC transporter localization and function | Q37570698 | ||
| Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer | Q37591742 | ||
| Genistein as a Potential Anticancer Agent against Ovarian Cancer. | Q37618157 | ||
| Interactions of gut microbiota with functional food components and nutraceuticals. | Q37633094 | ||
| Targeting silibinin in the antiproliferative pathway | Q37667106 | ||
| Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies | Q37687437 | ||
| Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides | Q37710997 | ||
| Dietary fiber as a carrier of dietary antioxidants: an essential physiological function | Q37818118 | ||
| Metabolic engineering of flavonoids in plants and microorganisms | Q37898054 | ||
| A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship. | Q37944848 | ||
| Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents | Q38005689 | ||
| Genistein and daidzein: different molecular effects on prostate cancer | Q38069807 | ||
| The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs | Q38071690 | ||
| Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation | Q38075335 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P2507 | corrigendum / erratum | Erratum to: Cancer chemoprevention through dietary flavonoids: what's limiting? | Q42351612 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polyphenol | Q290439 |
| dietary supplement | Q645858 | ||
| neoplasm | Q1216998 | ||
| flavonoid | Q3561192 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 50 | |
| P577 | publication date | 2017-06-19 | |
| P1433 | published in | Chinese Journal of Cancer | Q15760211 |
| P1476 | title | Cancer chemoprevention through dietary flavonoids: what's limiting? | |
| P478 | volume | 36 |
| Q55070865 | Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis. |
| Q93188465 | Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents |
| Q89791826 | Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides |
| Q58693659 | Data on cell survival, apoptosis, ceramide metabolism and oxidative stress in A-494 renal cell carcinoma cell line treated with hesperetin and hesperetin-7-O-acetate |
| Q57591520 | Dietary Flavonoids and the Risk of Colorectal Cancer: An Updated Meta-Analysis of Epidemiological Studies |
| Q93189950 | Effect of Different Drying Techniques on Antioxidant Capacity of Two Romanian Red Grape Cultivars |
| Q42351612 | Erratum to: Cancer chemoprevention through dietary flavonoids: what's limiting? |
| Q88914452 | Evaluation of Hydro-Alcoholic Extract of Trifolium Pratens L. for Its Anti-Cancer Potential on U87MG Cell Line |
| Q91796711 | Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets |
| Q47855461 | Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell |
| Q90522877 | Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells |
| Q89804795 | Improved Pharmacokinetics and Tissue Uptake of Complexed Daidzein in Rats |
| Q38639579 | Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway. |
| Q47678496 | Prevention of recognition memory loss and moderation of mitochondrial dynamic tendency toward fusion by flavone derivatives in Aβ-injected rats: a comparison between two flavonoids with different polarity |
| Q64922234 | Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids. |
| Q64230467 | The Therapeutic Potential of Naringenin: A Review of Clinical Trials |
| Q42351612 | Erratum to: Cancer chemoprevention through dietary flavonoids: what's limiting? | main subject | P921 |
Search more.